1. Home
  2. NVAX vs ALGT Comparison

NVAX vs ALGT Comparison

Compare NVAX & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • ALGT
  • Stock Information
  • Founded
  • NVAX 1987
  • ALGT 1997
  • Country
  • NVAX United States
  • ALGT United States
  • Employees
  • NVAX N/A
  • ALGT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ALGT Air Freight/Delivery Services
  • Sector
  • NVAX Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • NVAX 1.3B
  • ALGT 1.1B
  • IPO Year
  • NVAX 1995
  • ALGT 2006
  • Fundamental
  • Price
  • NVAX $9.23
  • ALGT $61.87
  • Analyst Decision
  • NVAX Buy
  • ALGT Hold
  • Analyst Count
  • NVAX 7
  • ALGT 9
  • Target Price
  • NVAX $14.29
  • ALGT $72.78
  • AVG Volume (30 Days)
  • NVAX 4.4M
  • ALGT 329.0K
  • Earning Date
  • NVAX 11-11-2025
  • ALGT 10-29-2025
  • Dividend Yield
  • NVAX N/A
  • ALGT N/A
  • EPS Growth
  • NVAX N/A
  • ALGT N/A
  • EPS
  • NVAX 2.54
  • ALGT N/A
  • Revenue
  • NVAX $1,078,718,000.00
  • ALGT $2,578,359,000.00
  • Revenue This Year
  • NVAX $60.81
  • ALGT $5.95
  • Revenue Next Year
  • NVAX N/A
  • ALGT $5.33
  • P/E Ratio
  • NVAX $3.62
  • ALGT N/A
  • Revenue Growth
  • NVAX 9.22
  • ALGT 3.17
  • 52 Week Low
  • NVAX $5.01
  • ALGT $39.80
  • 52 Week High
  • NVAX $13.77
  • ALGT $107.57
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 60.85
  • ALGT 52.71
  • Support Level
  • NVAX $8.32
  • ALGT $58.03
  • Resistance Level
  • NVAX $9.05
  • ALGT $64.20
  • Average True Range (ATR)
  • NVAX 0.41
  • ALGT 2.69
  • MACD
  • NVAX 0.06
  • ALGT -0.16
  • Stochastic Oscillator
  • NVAX 68.06
  • ALGT 60.05

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

Share on Social Networks: